Test Price
2,800 AED✅ Home Collection Available
SLC2A1 Gene Epilepsy (Idiopathic Generalized Type 12) Genetic Test in UAE | 2,800 AED
Executive Summary & Core Metrics
Achieved through ISO‑accredited NGS processing with full SLC2A1 gene coverage and concurrent CNV detection
Hospital‑grade phlebotomy with ISO‑certified temperature‑controlled logistics, available daily 8 AM‑11 PM across all UAE emirates
Personalised telephonic interpretation by a Consultant Medical Geneticist to discuss implications and therapeutic next steps
Verify your policy instantly via WhatsApp +971 54 548 8731
Test Overview & Methodology
This advanced Next‑Generation Sequencing (NGS) test performs comprehensive analysis of the full SLC2A1 gene to identify pathogenic variants associated with Idiopathic Generalized Epilepsy Type 12 (GLUT1 deficiency syndrome). The assay provides definitive molecular confirmation when clinical phenotype and family history suggest this treatable neurometabolic condition, enabling precise genetic counselling and timely initiation of a ketogenic diet when indicated.
| Feature | Our Test (NGS Full‑Gene Analysis) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | > 99 % analytical sensitivity for SNVs, indels and exon‑level CNVs | High for point mutations, limited CNV detection capability |
| Methodology | Targeted NGS panel with bioinformatic CNV caller, Illumina platform | Bidirectional Sanger sequencing of coding exons only |
| Turnaround Time | 3–4 Weeks | 6–8 Weeks |
Physician Insight & Safety Protocols
"Confirming a molecular diagnosis of GLUT1 deficiency through SLC2A1 sequencing fundamentally changes the clinical trajectory for patients with early‑onset epilepsy. A positive result directly supports the introduction of a ketogenic diet, which can markedly reduce seizure burden and improve neurodevelopmental outcomes in this specific epileptic syndrome." – Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Safety Advisory
Critical Medication Advisory
Patients must not discontinue prescribed anti‑epileptic drugs without direct supervision from their treating neurologist. Sudden cessation of anticonvulsant therapy may provoke life‑threatening seizure escalation or status epilepticus.
Exclusion Criteria & Emergency Red Flags
- This test requires a peripheral whole blood sample or extracted genomic DNA; individuals unable to provide such a specimen should seek alternative genetic counselling pathways.
- Patients with known severe coagulopathy or bleeding disorders must notify the phlebotomist prior to sample collection so appropriate precautions can be taken.
- Immediate emergency department attendance is mandatory if a seizure persists beyond 5 minutes, if breathing becomes laboured or irregular, or if the patient loses consciousness.
Patient FAQ & Clinical Guidance
1. What is the SLC2A1 gene test, and how does it help diagnose epilepsy?
The SLC2A1 genetic test detects disease‑causing mutations in the GLUT1 glucose transporter gene, providing molecular confirmation of idiopathic generalized epilepsy type 12 and directly guiding ketogenic diet therapy as a precision treatment approach.
2. Is home sample collection available across all UAE emirates?
Yes, our DHA‑licensed mobile phlebotomy team performs hospital‑grade home collection using temperature‑controlled cold‑chain logistics from 8 AM to 11 PM across Abu Dhabi, Dubai, Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah.
3. How is my genetic data protected under UAE law?
All genetic information is processed and stored under the strict requirements of Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Explicit informed consent is obtained prior to testing, and laboratory operations maintain ISO 9001:2015 certification for quality management.
4. What does the test result mean for my treatment plan?
A confirmed pathogenic SLC2A1 variant strongly supports the use of a ketogenic diet, which can significantly reduce or eliminate seizures in many cases. Your Consultant Medical Geneticist will explain the implications in detail and coordinate with your neurologist to adjust your treatment strategy accordingly.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143). All genetic testing services at DNA Labs UAE comply with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL), Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields for health data security, and Federal Decree‑Law No. 4 of 2016 on Medical Liability governing clinical testing safety and patient consent protocols. Laboratory quality management is certified under ISO 9001:2015, and sample handling follows ISO 15189 standards for medical laboratory excellence.
Clinical & Logistical Metadata
| Test Name | SLC2A1 Gene Epilepsy (Idiopathic Generalized Type 12) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA) or Extracted Genomic DNA |
| Methodology Used | Next‑Generation Sequencing (NGS), Full Gene Coverage including Exon‑Level CNV Detection |
| ICD-10-CM Code | G40.3 (Idiopathic Generalized Epilepsy) |
| LOINC Code | 91634-4 (SLC2A1 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA Facility License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE. Corporate Lab: DNA Labs UAE. |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians